(Q46315298)

English

Efficacy and Safety of ABT-126 in Subjects with Mild-to-Moderate Alzheimer's Disease on Stable Doses of Acetylcholinesterase Inhibitors: A Randomized, Double-Blind, Placebo-Controlled Study

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

21 December 2017

http://europepmc.org/abstract/MED/26967214

Efficacy and Safety of ABT-126 in Subjects with Mild-to-Moderate Alzheimer's Disease on Stable Doses of Acetylcholinesterase Inhibitors: A Randomized, Double-Blind, Placebo-Controlled Study (English)

1 reference

Europe PubMed Central

21 December 2017

http://europepmc.org/abstract/MED/26967214

Alzheimer's disease

0 references

1 reference

based on heuristic

inferred from title

7

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26967214%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

author name string

Hana Florian

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26967214%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

Andreas Meier

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26967214%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

Serge Gauthier

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26967214%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

Stanley Lipschitz

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26967214%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

Yunzhi Lin

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26967214%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

Qi Tang

6

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26967214%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

Weining Z Robieson

8

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26967214%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

Laura M Gault

9

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26967214%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

publication date

29 February 2016

1 reference

Europe PubMed Central

21 December 2017

http://europepmc.org/abstract/MED/26967214

Journal of Alzheimer's Disease

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26967214%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

51

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26967214%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26967214%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

1237-1247

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26967214%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

Targeting the nicotinic alpha7 acetylcholine receptor to enhance cognition in disease

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150978

21 January 2018

Alzheimer disease: current concepts and emerging diagnostic and therapeutic strategies

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150978

21 January 2018

Nicotinic acetylcholine receptors: from basic science to therapeutics

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150978

21 January 2018

Quantitative assessment of nicotinic acetylcholine receptor proteins in the cerebral cortex of Alzheimer patients.

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150978

21 January 2018

Decreased protein levels of nicotinic receptor subunits in the hippocampus and temporal cortex of patients with Alzheimer's disease

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150978

21 January 2018

PET imaging of cortical 11C-nicotine binding correlates with the cognitive function of attention in Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150978

21 January 2018

Safety and clinical effects of EVP-6124 in subjects with Alzheimer's disease currently or previously receiving an acetylcholinesterase inhibitor medication

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150978

21 January 2018

Normalizing effects of EVP-6124, an α-7 nicotinic partial agonist, on event-related potentials and cognition: a proof of concept, randomized trial in patients with schizophrenia

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150978

21 January 2018

A randomized exploratory trial of an α-7 nicotinic receptor agonist (TC-5619) for cognitive enhancement in schizophrenia

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150978

21 January 2018

A randomized, placebo-controlled study investigating the nicotinic α7 agonist, RG3487, for cognitive deficits in schizophrenia

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150978

21 January 2018

In vivo pharmacological characterization of a novel selective alpha7 neuronal nicotinic acetylcholine receptor agonist ABT-107: preclinical considerations in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150978

21 January 2018

Effects of α7 nicotinic acetylcholine receptor agonists on antipsychotic efficacy in a preclinical mouse model of psychosis.

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150978

21 January 2018

Immediate and sustained improvements in working memory after selective stimulation of α7 nicotinic acetylcholine receptors.

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150978

21 January 2018

Selective alpha7 nicotinic receptor activation by AZD0328 enhances cortical dopamine release and improves learning and attentional processes.

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150978

21 January 2018

Effects of the nicotinic α7 receptor partial agonist GTS-21 on NMDA-glutamatergic receptor related deficits in sensorimotor gating and recognition memory in rats

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150978

21 January 2018

Alpha 7 nicotinic acetylcholine receptor agonist GTS-21 mitigates isoflurane-induced cognitive impairment in aged rats.

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150978

21 January 2018

Pro-cognitive and antipsychotic efficacy of the alpha7 nicotinic partial agonist SSR180711 in pharmacological and neurodevelopmental latent inhibition models of schizophrenia.

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150978

21 January 2018

SSR180711, a novel selective alpha7 nicotinic receptor partial agonist: (II) efficacy in experimental models predictive of activity against cognitive symptoms of schizophrenia.

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150978

21 January 2018

Identifiers

10.3233/JAD-150978

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26967214%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

release_xesjiadhbnfinek2imoerg4jr4

1 reference

https://api.fatcat.wiki/v0/release/xesjiadhbnfinek2imoerg4jr4

24 November 2022

based on heuristic

mapped directly with Wikidata item

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26967214%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46315298&oldid=2104529820"